Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Reduced Inflammation

Research synthesisVery low evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 database entries, all 5 report beneficial effects on inflammation, with effect sizes ranging from small to moderate (predominantly moderate). However, only 1 study (a randomized controlled trial) provides statistically significant findings; this study used a different Lactobacillus strain (L. plantarum TWK10) rather than L. brevis SBC8803. The remaining studies are narrative reviews or mechanistic studies on other strains, offering indirect evidence. No studies directly investigated L. brevis SBC8803 for inflammation.

Caveats: None of the 5 studies directly tested Lactobacillus brevis SBC8803; three studies reviewed probiotics in general or postbiotics, and the single RCT examined a different strain (L. plantarum TWK10). Therefore, the evidence for L. brevis SBC8803 reducing inflammation is indirect and of very low certainty. No dose or population-specific conclusions can be drawn.

Generated May 11, 2026
8 of 8 papers
Back to top